Pharmaceutical Regulatory Affairs: Open Access

Bandameedi R

Publications

• Review Article
  A Case Study on National List of Essential Medicines (NLEM) in India and WHO EML 2015-Overview
  Author(s): Bandameedi R, Mohammed S and Soma HBandameedi R, Mohammed S and Soma H
  
  Availability of modern medicine increased all over the world due to huge expansion of the global Pharma market. At the same time misuse as well as accessibility of the most of essential drugs to majority of the population was denied due to cost-effectiveness of healthcare delivery combined with poor procurement policies and poor prescribing practices. During the recent years, the national list of India has assumed immense importance to improve access to medicines in India. It is therefore necessary to understand policies and guidelines followed in developing WHO essential drug list and national list of essential medicines. In thi.. Read More»
  DOI: 10.4172/2167-7689.1000159

  Abstract PDF